Author

Antonio Rueda

Andalusian Centre for Nanomedicine and BiotechnologyORCID 0000-0001-5890-0149Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Assay:flow cytometry· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Anna SchuhiD· 1 shared Anthony Cutts· 1 shared Arman ArdalaniD· 1 shared Beatriz Martínez-GálveziD· 1 shared Brian David NicholsoniD· 1 shared Bronwen Miller· 1 shared Carolyn L. Tregidgo· 1 shared Chun‐Xiao SongiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Anna SchuhORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 13, 2025

Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic cutaneous melanoma

Juan Luis Onieva, Elísabeth Pérez-Ruiz, Vesa Vilkki…·Antonio Rueda‐Domínguez

This study identifies an 82-gene transcriptomic signature predicting immune checkpoint inhibitor resistance in metastatic cutaneous melanoma using tumor and immune cell profiling.

DOI 10.1101/2025.08.13.670062

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintSep 29, 2023

Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals

Dimitris V. Vavoulis, Anthony Cutts, Nishita Thota…·Anna Schuh

This paper develops a bioinformatics pipeline combining TAPS and whole-genome sequencing to detect ctDNA in cancer patients, achieving 85.2% sensitivity with 100% specificity.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky